It’s no longer a question if these companies will grow; it’s about how and where they choose to grow to offer flexibility, manage risk and support long-term stability.
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Austin's life sciences sector is undergoing rapid ...
Life science campuses of yesteryear' tended to be remote, all-work-no-play settings Today's versions are city-centered and ...
Generative AI-driven analytics platform brings together owned and public data with Oracle Health Real-World Data's millions of de-identified longitudinal EHR records Delivers powerful, deep insights ...
Life sciences leaders say AI agents will be "essential" within two years. 97% say trusted data is essential for effective use of AI agents. 81% of R&D leaders surveyed are "very excited" about using ...
Life Science Cares, an industry philanthropic organization, turns 10 in April. Now in five cities and Switzerland, the organization remains focused on fighting poverty.
Experts from Dechert, BlueRock Therapeutics, Merck, Seaport Therapeutics, and Ventus Therapeutics examine the impact of recent court rulings following Amgen v. Sanofi on broad genus claims within life ...
Over the past four years, private equity (PE) firms that invested in life science assets have faced a difficult reality. While many investors still debate whether some sectors of the market are in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results